Envestnet Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
GCM
NIMC
Envestnet Asset Management's CELL Position: Q3 2022 in Review
Envestnet Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 30,370 shares — an estimated $151K sold.
Envestnet Asset Management first reported a position in CELL in Q1 2021 and held it in 3 quarters. The position peaked at $544K in Q2 2021. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.
- Envestnet Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Envestnet Asset Management sold 30,370 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $151K.
- Envestnet Asset Management first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 3 quarters.
- Envestnet Asset Management's PhenomeX Inc. Common Stock position peaked at $544K in Q2 2021.
- 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.
Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.